This skid-mounted industrial virus inactivation vessel system is engineered for dedicated low-pH incubation, solvent/detergent (S/D) treatment and other validated viral clearance steps in monoclonal antibodies, plasma-derived products, recombinant proteins and viral vector bulk drug substance production, complying strictly with ICH Q5A, global cGMP and biopharma regulatory standards.
The vessel body and full wetted piping adopt ultra-electropolished 316L stainless steel with hygienic orbital welding, dead-leg-free fully drainable layout, supporting automated CIP cleaning and SIP sterilization to eliminate cross-contamination risks between product batches. Built-in jacketed temperature control system, high-efficiency low-shear agitation assembly and precise pH dosing manifolds maintain uniform temperature, pH and mixing homogeneity across the entire liquid volume throughout the holding period, avoiding localized pH drift or insufficient inactivation that compromises viral reduction factor (VRF) validation results.
Equipped with online pH, temperature, pressure and mixing speed real-time monitoring sensors, the platform executes full closed-loop automatic control: automatic acid/base dosing to target inactivation pH, accurate timing of hold duration, real-time trend recording and automatic hold-time completion signal output to trigger material transfer to the next purification unit. Sealed fully closed processing design prevents exogenous contamination during the critical viral safety control step.
The automation architecture follows ISA-88 batch control specifications, stores multiple validated inactivation process recipes, runs unattended full-cycle operation, and generates tamper-proof electronic batch records and complete audit trails, fully supporting regulatory inspection and viral validation documentation submission.
Each integrated system undergoes comprehensive FAT testing prior to shipment, featuring seamless inline connection with upstream depth filtration and downstream chromatography skids. Standard commercial-scale volumes support stable process scale-up from pilot batches to full commercial manufacturing, delivering reliable, repeatable viral safety assurance for biologic bulk production lines.
